Immunotherapy of surgical malignancies.
Morse
Michael A
MA
Duke University Medical Center, Durham, North Carolina, USA.
Lyerly
H Kim
HK
Clay
Timothy M
TM
Abdel-Wahab
Omar
O
Chui
Stephen Y
SY
Garst
Jennifer
J
Gollob
Jared
J
Grossi
Peter M
PM
Kalady
Matthew
M
Mosca
Paul J
PJ
Onaitis
Mark
M
Sampson
John H
JH
Seigler
Hilliard F
HF
Toloza
Eric M
EM
Tyler
Douglas
D
Vieweg
Johannes
J
Yang
Yiping
Y
D000951:Antigens, Neoplasm / Q000276:immunology / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000628:therapy; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007680:Kidney Neoplasms / Q000628:therapy; D008175:Lung Neoplasms / Q000628:therapy; D009369:Neoplasms / Q000276:immunology* / Q000601:surgery / Q000628:therapy*; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines